FDA’s revolving door reveals Pazdur as new CDER head

"FDA’s revolving door reveals Pazdur as new CDER head" was originally created and published by Pharmaceutical Technology, a ...
Le Lézard

Pace Surgical Receives FDA 510(k) Clearance for Ultra Compression Screw System for Foot and Ankle Reconstruction

MALVERN, PA / ACCESS Newswire / November 12, 2025 / Pace Surgical, a Runway Healthcare portfolio company pioneering ...
The Manila Times

Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease

Artiva remains on track to share initial clinical response data and conduct U.S. Food and Drug Administration (FDA) ...
The Manila Times

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

Positive FDA feedback confirms clear clinical pathway for BX011 targeting S. aureus in Diabetic Foot Infections, building on Company’s prior Phase 2 success ...